Process and Outcome Evaluation of the Centers for Disease Control and Prevention’s Think. Test. Treat TB Health Communications Campaign, United States, March–September 2022
Public Health Reports® · 2025
DOI: 10.1177/00333549241268644 ↗Kurz gefasst
Fachartikel in der Zeitschrift Public Health Reports®, 2025. Verfasst von Elise Caruso und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, A…. Hauptthemen laut MEDLINE: Centers for Disease Control and Prevention, U.S., Health Promotion, Health Knowledge, Attitudes, Practice, Latent Tuberculosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CDC HHS, Centers for Disease Control and Prevention.
Abstract (Originalsprache)
Objectives
The Think. Test. Treat TB health communications campaign aims to increase the awareness of latent tuberculosis infection (LTBI) primarily among people born in the Philippines and Vietnam and other non–US-born groups (consumers) and the health care providers (providers) who serve them. We conducted a process evaluation to assess reach and audience engagement and an outcome evaluation to assess awareness, knowledge, perceptions, and behavioral intentions among audiences of the campaign.
Methods
To evaluate the process, the Centers for Disease Control and Prevention measured exposure to (eg, with impressions [total advertisements]) and engagement with (eg, online clicks) the campaign during its rollout (March–September 2022). After the rollout, to evaluate outcomes, we administered online surveys to consumers and providers who were exposed and not exposed to the campaign.
Results
The Think. Test. Treat TB campaign resulted in >33 million impressions, >2000 materials downloaded from the internet, and >33 000 materials shipped. Of 173 consumers who completed the evaluation survey, 123 (71.1%) were exposed to the campaign, with 108 (87.8%) reporting intention to ask their provider about tuberculosis (TB) during their next visit. Of 44 providers who completed the evaluation survey, 24 (54.5%) did not feel that they were the intended audience of the campaign, yet all felt the campaign materials were relevant to their patients, and 42 (95.5%) felt the materials were relevant to providers who serve patients at risk for TB.
Conclusion
The Think. Test. Treat TB campaign was successful in raising awareness of LTBI among the intended audiences. Continuing engagement with key audiences about LTBI to encourage testing and treatment is integral to eliminate TB in the United States.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
- Oak Ridge Institute for Science and Education, Oak Ridge, TN, USA.
ORCID-Profile: Elise Caruso
Förderung
- CDC HHS
- Centers for Disease Control and Prevention
Zitieren
APA
Caruso, E., Parmer, J., Allen, L., Maiuri, A., Mangan, J., Bouwkamp, B., & DeLuca, N. (2025). Process and Outcome Evaluation of the Centers for Disease Control and Prevention’s Think. Test. Treat TB Health Communications Campaign, United States, March–September 2022. Public Health Reports®. https://doi.org/10.1177/00333549241268644
Vancouver
Caruso E, Parmer J, Allen L, Maiuri A, Mangan J, Bouwkamp B, et al. Process and Outcome Evaluation of the Centers for Disease Control and Prevention’s Think. Test. Treat TB Health Communications Campaign, United States, March–September 2022. Public Health Reports®. 2025. doi:10.1177/00333549241268644
BibTeX
@article{Caruso2025,
author = {Caruso, Elise and Parmer, John and Allen, Leeanna and Maiuri, Allison and Mangan, Joan and Bouwkamp, Beth and DeLuca, Nickolas},
title = {Process and Outcome Evaluation of the Centers for Disease Control and Prevention’s Think. Test. Treat TB Health Communications Campaign, United States, March–September 2022},
journal = {Public Health Reports®},
year = {2025},
doi = {10.1177/00333549241268644}
}
EUVIMED